Dr. Michael A. Thomas, M.D.
Fertility (Reproductive Endocrinology) (Reproductive Endocrinology Physician)
At a glance
- Medical school
- University of Illinois College of Med (Chi/Peor/Rock/Chm-Urb) (1984)
- Years since graduation
- 42
- In the NPI registry since
- 2006
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1984Medical school: University of Illinois College of Med (Chi/Peor/Rock/Chm-Urb)
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Reproductive Endocrinology Physician primary
OH license 35-056711 · KY license 33328 -
Gynecology Physician
KY license 33328 · OH license 35-056711 -
Obstetrics & Gynecology Physician
KY license 33328 · OH license 35-056711 -
Obstetrics Physician
KY license 33328 · OH license 35-056711
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Map: Fertility (Reproductive Endocrinology) per capita by county →
Where they work
Medical groups
- University of Cincinnati Physicians Company LLC (1,506 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Finasteride Other prescribers in West Chester, OH | 12 |
| Estradiol Other prescribers in West Chester, OH | 11 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 2 companies reported 7 payments worth $431 in total to this clinician.
| Coopersurgical, Inc. | $265 |
|---|---|
| Ferring Pharmaceuticals Inc. | $167 |
| Food and Beverage | $431 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 5 industry-funded studies in 2025, from 5 companies. The companies reported $100,475 in research payments for these studies, mostly to the institutions running them.
- PROGRESS - Subcutaneous PROgesterone in fRozen-thawed single Euploid blaStocyst tranSfer
Ibsa Institut Biochimique SA - VITROS Immunodiagnostic Products Progesterone 2 Apparently Healthy Collection Protocol
Ortho-clinical Diagnostics, Inc. - Study name not reported
Organon Llc - Evaluation of Efficacy, Safety and Tolerability of VeraCept IUS
Sebela Women's Health Inc. · Active, not recruiting · NCT03633799 - Study of the Safety and Contraceptive Efficacy of Relugolix Combination Therapy in Women With Uterine Fibroids or Endometriosis Who Are at Risk for Pregnancy
Sumitomo Pharma America, Inc. · Completed · NCT04756037
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.